Who are the vulnerable lung cancer patients at risk for not receiving first-line curative or palliative treatment?

CONCLUSIONS: Several factors are associated with not receiving guideline-recommended NSCLC treatment with age, performance status, comorbidity and stage being most predictive of no treatment receipt. Efforts should be made to develop support for vulnerable lung cancer patients to improve adherence to optimal first-line therapy.PMID:37656828 | DOI:10.1080/0284186X.2023.2252581

Source: Acta Oncologica - September 1, 2023 Category: Cancer & Oncology Authors: Rikke Langballe Jakobsen Erik Iachina Maria Karlsen Randi Valbj ørn Ehlers Jeanette Haar Svendsen Mads Nordahl Bodtger Uffe Hilberg Ole Dalton Susanne Oksbjerg Bidstrup Pernille Envold Source Type: research